微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 65.95% | -1.69% | -0.81% | 39/159 | -1.59% | 海创药业 | 99.57% | 行业排名> |
| 2025-06-30 | 66.49% | -0.3% | -0.23% | 37/159 | 15.28% | 海创药业 | 99.52% | 行业排名> |
| 2025-03-31 | 66.64% | 0.91% | -0.66% | 33/159 | 32.3% | 艾力斯 | 96.74% | 行业排名> |
| 2024-12-31 | 67.09% | 0.68% | 0% | 39/159 | 51.78% | 首药控股 | 98.96% | 行业排名> |
| 2024-09-30 | 67.09% | -0.27% | 0.59% | 36/159 | 22.81% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 66.69% | -2% | 0.99% | 37/159 | 33.25% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 66.04% | -2.82% | -0.89% | 34/159 | 51.56% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 66.63% | -2.34% | -0.94% | 39/159 | 51.39% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 67.27% | -1.61% | -1.16% | 39/159 | 32.56% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 68.06% | -0.63% | 0.15% | 38/159 | 38.45% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 67.96% | -0.71% | -0.41% | 38/159 | 52.78% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 68.23% | -1.83% | -0.19% | 41/159 | 53.66% | 迈威生物 | 99.75% | 行业排名> |
| 2022-09-30 | 68.36% | 2% | -0.18% | 41/159 | 6.2% | 迈威生物 | 99.67% | 行业排名> |
| 2022-06-30 | 68.49% | -3.04% | 0.06% | 46/159 | 21.37% | 迈威生物 | 99.44% | 行业排名> |
| 2022-03-31 | 68.44% | 2% | -1.53% | 40/159 | 54.28% | 迈威生物 | 98.57% | 行业排名> |
| 2021-12-31 | 69.51% | -2.21% | -1.59% | 44/159 | 55.1% | 首药控股 | 99.93% | 行业排名> |
| 2021-06-30 | 70.63% | 2% | -0.63% | 37/159 | 47.23% | 艾力斯 | 99.41% | 行业排名> |
| 2020-12-31 | 71.08% | -5.93% | -5.93% | 36/159 | -145.9% | 艾力斯 | 98.7% | 行业排名> |
| 2019-12-31 | 75.56% | 1.9% | 1.9% | 26/159 | -1222.98% | 艾力斯 | 99.4% | 行业排名> |
| 2018-12-31 | 74.15% | 2% | 2% | 28/159 | -208.09% | 首药控股 | 99.94% | 行业排名> |